BIG PHARMA EARNINGS WATCH: MERCK, ELI LILLY, AMGEN, PFIZER, GLAXOSMITHKLINE, ASTRAZENECA
Feb 18, 2022
New Earnings Reports Show Big Pharma Giants Continue to Reap Massive Profits,… Read More
© 2024 CSRXP- All Rights Reserved
Updates
CSRXP STATEMENT ON CONFIRMATION OF DR. ROBERT CALIFF AS COMMISSIONER OF U.S. FOOD AND DRUG ADMINISTRATION
Feb 15, 2022
FDA Can Play a Critical Role in Holding Big Pharma Accountable and Promoting… Read More
BIG PHARMA EARNINGS WATCH: ABBVIE, SANOFI, BRISTOL-MYERS SQUIBB, NOVARTIS
Feb 11, 2022
New Q4 Earnings Reports Underscore How Big Pharma’s Pandemic Price Hikes,… Read More
CSRXP POLL: VOTERS SEE THROUGH BIG PHARMA’S BLAME GAME, WANT WASHINGTON TO LOWER DRUG PRICES & HOLD DRUG COMPANIES ACCOUNTABLE
Feb 7, 2022
Broad Majorities of Americans Blame Pharmaceutical Industry for Out-of-Control… Read More
SECOND OPINION: PHRMA STUDY REHASHES DEBUNKED SUPPLY CHAIN BLAME GAMES
Feb 3, 2022
Big Pharma Sidesteps Industry’s Own Price Hikes and Egregious Practices in… Read More
CSRXP: BIG PHARMA’S BUSINESS-AS-USUAL APPROACH TO JANUARY PRICE HIKES UNDERSCORES URGENCY FOR RX SOLUTIONS
Feb 2, 2022
Drug Companies Increased Prices on 785 Brand Name Products in First Month of… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Jan 28, 2022
J&J Surpasses Wall Street Expectations, Nearly Tripling Year-Over-Year… Read More
ICYMI: NEW REPORTS UNDERSCORE URGENCY FOR ACTION TO REIN IN BIG PHARMA’S OUT-OF-CONTROL DRUG PRICES
Jan 21, 2022
CBO Finds Net Prices for Brand Name Drugs More Than Doubled from 2009-2018;… Read More
DOSE OF REALITY: NEW ANALYSIS UNDERSCORES HOW OFTEN BIG PHARMA’S PATENTS ARE UNRELATED TO CLINICAL INNOVATION
Jan 19, 2022
Study Finds Just Six Percent of Drug Patents in Infringement Suits Were for… Read More
CSRXP STATEMENT ON PROPOSED CMS COVERAGE DECISION FOR ADUHELM
Jan 12, 2022
DECISION WILL HELP PROTECT SENIORS, TAXPAYERS AND THE U.S. HEALTH SYSTEM FROM… Read More
CSRXP STATEMENT AHEAD OF COMMITTEE VOTE FOR DR. ROBERT CALIFF TO LEAD U.S. FOOD AND DRUG ADMINISTRATION
Jan 12, 2022
Next FDA Commissioner Must Promote Competition, Transparency And Value In The… Read More
SECOND OPINION: BIG PHARMA CEO CLAIMS “COURAGEOUS” TO PRICE UNPROVEN TREATMENT 10 TIMES ESTIMATE OF FAIR PRICE
Jan 11, 2022
Biogen Decision to Change Aduhelm Price After Public Outcry Demonstrates Big… Read More